CANADA PENSION PLAN INVESTMENT BOARD - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 171 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
CANADA PENSION PLAN INVESTMENT BOARD ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$3,000
-25.0%
1210.0%0.00%
Q1 2022$4,0000.0%1210.0%0.00%
Q4 2021$4,000
-88.2%
121
-83.4%
0.00%
Q3 2021$34,000
-78.9%
727
-75.2%
0.00%
Q2 2021$161,000
-54.4%
2,927
-57.2%
0.00%
Q1 2021$353,000
-65.3%
6,845
-70.8%
0.00%
-100.0%
Q4 2020$1,017,000
-42.2%
23,480
-28.6%
0.00%
-50.0%
Q2 2020$1,759,000
-32.7%
32,886
-55.4%
0.00%
-42.9%
Q1 2020$2,614,000
-40.7%
73,686
-20.2%
0.01%
-22.2%
Q4 2019$4,411,000
+233.7%
92,386
+126.4%
0.01%
+200.0%
Q3 2019$1,322,000
+21.7%
40,805
+87.5%
0.00%
+50.0%
Q2 2019$1,086,000
-61.5%
21,766
-55.8%
0.00%
-60.0%
Q4 2017$2,818,000
-8.0%
49,300
+7.4%
0.01%
-16.7%
Q3 2017$3,064,000
+23.8%
45,900
-4.6%
0.01%0.0%
Q2 2017$2,475,000
+39.0%
48,100
+57.7%
0.01%
+20.0%
Q1 2017$1,781,000
+252.7%
30,500
+152.1%
0.01%
+150.0%
Q4 2016$505,000
-34.1%
12,100
-16.6%
0.00%
-33.3%
Q3 2016$766,000
+66.2%
14,500
+31.8%
0.00%
+50.0%
Q2 2016$461,000
+2.2%
11,000
-0.9%
0.00%0.0%
Q1 2016$451,000
-2.2%
11,100
+56.3%
0.00%0.0%
Q4 2015$461,000
+723.2%
7,100
+787.5%
0.00%
Q3 2015$56,000
-16.4%
800
+33.3%
0.00%
Q2 2015$67,0006000.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,661,605$61,137,0671.46%
Bellevue Group AG 4,013,500$92,190,0951.34%
Eagle Health Investments LP 267,630$6,147,4611.20%
ARMISTICE CAPITAL, LLC 3,460,000$79,476,2001.14%
Integral Health Asset Management, LLC 213,000$4,892,6100.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$10,428,3800.44%
ArrowMark Colorado Holdings LLC 1,557,705$35,780,4840.41%
FARALLON CAPITAL MANAGEMENT LLC 2,092,829$48,072,2820.27%
Virtus ETF Advisers LLC 9,932$228,1380.13%
JACOBS LEVY EQUITY MANAGEMENT, INC 614,533$14,115,8230.09%
View complete list of AGIOS PHARMACEUTICALS INC shareholders